# SLR Investment Corp. (SLRC)

> Source: Nexqual · https://nexqual.com/SLRC · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, SLR Investment Corp. (SLRC), nexqual.com/SLRC" · informational, not investment advice.

**Price:** USD 11.79 (+1.99% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 11.56 · day 11.56–11.8 · 52w 10.96–16.36 · market cap $643M · NMS

## Key facts
- Valuation: P/E 8.7x (avg 9.7x at the last 3 fiscal year-ends), net debt $731M.
- Analysts: Hold (mean 2.50 on a 1–5 scale) (8 analysts), mean target USD 14.69 (range 12–18).
- Total return with dividends: 1Y -15.7% vs S&P 500 +14.8%; 5Y +0.3% vs S&P 500 +79.1%.
- Next earnings: 2026-11-03, EPS estimate USD 0.32, revenue estimate $48.9M. All companies reporting that day: https://nexqual.com/earnings/2026-11-03
- Dividend: USD 1.44 a year (yield 12.45%), paid quarterly; latest ex-dividend date 2026-09-11; annual dividends fell 0.1% a year 2022–2025.
- Short interest: 2.35% of float (as of 2026-10-15), 3.1 days to cover.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Net income | $59.6M | $18.3M | $76.4M | $95.8M | $92.5M | $73.8M |
| EPS (diluted) | $1.41 | $0.35 | $1.40 | $1.76 | $1.70 | — |
| Cash + short-term investments | $1.99B | $2.50B | $344M | $414M | $364M | — |
| Total debt | $1.09B | $1.09B | $1.18B | $1.03B | $1.15B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 8.7x · Earnings yield 11.47% · Net debt $731M · EV $1.37B
P/E at fiscal year-ends: Dec 2025 9.1x, Dec 2024 9.2x, Dec 2023 10.7x.

## Analysts
Consensus Hold (mean 2.50 on a 1–5 scale), 8 analysts; mean target USD 14.69 (low 12, high 18).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-02 | JP Morgan | Target lowered | Underweight | $13.5 → $12 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -15.7% | +0.3% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | -15.8% | +0.1% |
| Volatility (annualized) | 25.0% | 21.1% |
| Max drawdown | -28.3% (Apr 2026→Oct 2026) | -31.2% (Oct 2021→Sep 2022) |

## Dividends
Annual dividend rate USD 1.44 per share, yield 12.45% at the current price. Paid over the last 12 months: USD 1.44 in 4 payments (quarterly).
Most recent ex-dividend date: Sep 11, 2026; payment date: Sep 25, 2026. To receive a dividend, shares must be owned before the ex-dividend date.
Latest change: cut 24.4% to USD 0.31 per payment from USD 0.41, starting with the Jun 12, 2026 ex-dividend date.
Payout ratio 113% of earnings (above 100%: dividends exceeded net income; for REITs and partnerships, cash-flow measures are more relevant) · 5-year average yield 10.65% · annual dividends fell 0.1% a year from 2022 to 2025.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-09-11 | USD 0.31 |
| 2026-06-12 | USD 0.31 |
| 2026-03-13 | USD 0.41 |
| 2025-12-12 | USD 0.41 |
| 2025-09-12 | USD 0.41 |
| 2025-06-13 | USD 0.41 |
| 2025-03-14 | USD 0.41 |
| 2024-12-13 | USD 0.41 |
Total by calendar year: 2022 USD 1.643 · 2023 USD 1.643 · 2024 USD 1.64 · 2025 USD 1.64.

## Short interest
1,164,489 shares sold short, 2.35% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 1,149,492 shares (+1.3%). Days to cover: 3.1 (short shares ÷ average daily volume).

## Peers (Asset Management)
BXSL (Blackstone Secured Lending Fund) USD 23.52 +1.38% · PDI (PIMCO Dynamic Income Fund) USD 14.33 +1.63% · VCTR (Victory Capital Holdings, Inc. ) USD 113.81 +1.73% · AMG (Affiliated Managers Group, Inc.) USD 399.02 +1.47% · SEIC (SEI Investments Company) USD 104.73 +1.48% · IVZ (Invesco Ltd) USD 29.02 +1.19%

## More
Full page: https://nexqual.com/SLRC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)


Other companies that name SLRC in their own reports (relationship from SLRC's side):

| Relationship | Company | Their filing | Sentence |
|---|---|---|---|
| partner | TREACE MEDICAL CONCEPTS, INC. (TMCI) | 10-K 2026-02-27 | "Net cash provided by financing activities for the year ended December 31, 2025 was $2.1 million, consisting primarily of $59.3 million of net cash proceeds from the new term loan agreement with SLR In…" |
| partner | Arcutis Biotherapeutics, Inc. (ARQT) | 10-K 2026-02-25 | "•our ability to satisfy the conditions, covenants, and obligations under our amended loan and security agreement with SLR Investment Corp.;" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.32 | $0.33 | -2.5% | $48.9M | 8 |
| Next quarter (ends 2026-12-31) | $0.33 | $0.33 | -0.5% | $49.4M | 7 |
| Current fiscal year (ends 2026-12-31) | $1.31 | $1.32 | -1.2% | $196.2M | 8 |
| Next fiscal year (ends 2027-12-31) | $1.33 | $1.33 | -0.1% | $199.5M | 8 |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.33 | $0.33 | In line | — |
| — | Quarter ended Mar 31, 2026 | $0.33 | $0.40 | Miss −17.5% | — |
| — | Quarter ended Dec 31, 2025 | $0.39 | $0.40 | Miss −2.5% | — |
| — | Quarter ended Sep 30, 2025 | $0.40 | $0.41 | Miss −2.4% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).